FDA ADE reports for Bedinvetmab (anti-NGF monoclonal antibody (chronic pain / osteoarthritis, dogs & cats)) — total reports, species & reaction breakdown

ade_bedinvetmab_adverse_events

ade en 2026-07-22

Bedinvetmab — FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Bedinvetmab is a anti-NGF monoclonal antibody (chronic pain / osteoarthritis, dogs & cats).

Total reports

Bedinvetmab: 18904

Reports by species (top entries)

Dog 18645
Human 130
Cat 8
Other Canids 4

Top reported reactions (VEDDRA terms, top entries)

Death by euthanasia 2370
Lethargy (see also Central nervous system depression in Neurological) 2229
Polydipsia 1618
Ataxia 1585
Seizure NOS 1531
Vomiting 1531
Polyuria 1515
Diarrhoea 1454
Urinary incontinence 1358
Death 1221

"Lack of efficacy" terms denote product-performance reports, not adverse reactions.

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b8.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).

Sources

openFDA animalandveterinary/event.json (FDA CVM ADE), pulled 2026-07-22

Machine access

AI agents: this page mirrors GET /api/v1/llm_context?topic=ade_bedinvetmab_adverse_events (max 500 tokens, whitelisted). Rate limit 60 req/min for recognized AI crawlers.

Raw JSON ↗ llm.txt OpenAPI